| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/04/2008 | EP1193250B1 Phenyl sulfamate derivatives |
| 06/04/2008 | EP1137436B1 Stimulation of T-cells against self antigens using CTLA-4 blocking agents |
| 06/04/2008 | EP1126782B1 Method for improved imaging and photodynamic therapy |
| 06/04/2008 | EP1019082B2 Use of a colony stimulating factor (csf) for enhancing collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 06/04/2008 | EP1015413B1 Use of an ingenane compound for the manufacture of a medicament for the treatment of cancer |
| 06/04/2008 | EP0958305B1 Inhibitions of the interaction between p53 and mdm2 |
| 06/04/2008 | EP0871452B1 Sulfate conjugates of ursodeoxycholic acid, and their beneficial use in inflammatory disorders and other applications |
| 06/04/2008 | EP0672143B1 Lymphotoxin-beta, lymphotoxin-beta complexes, pharmaceutical preparations and therapeutic uses thereof |
| 06/04/2008 | CN101193908A Organic compounds |
| 06/04/2008 | CN101193884A Tubulin inhibitor and process for its preparation |
| 06/04/2008 | CN101193878A Agent for treatment of solid tumor |
| 06/04/2008 | CN101193877A Agent for treatment of hematopoietic tumor |
| 06/04/2008 | CN101193861A Indole derivatives having antitumor activity |
| 06/04/2008 | CN101193854A Cinnamic, phenylpropiolic and phenylpropanoic acid derivatives useful as anti-tumour agents |
| 06/04/2008 | CN101193682A Pharmaceutical composition comprising an antiviral agent, an antitumoral agent or an antiparasitic agent, and an active agent selected among carveol, thymol, eugenol, borneol and carvacrol |
| 06/04/2008 | CN101193649A Use of plant cell membrane for the for the treatment of obesity |
| 06/04/2008 | CN101193632A Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 06/04/2008 | CN101190944A Human cytokine and use thereof |
| 06/04/2008 | CN101190925A Copper complex, preparation method and application thereof |
| 06/04/2008 | CN101190917A 3,4-dihydro-3-methyl-4-oxomidazo[5,1-d]-1,2,3,5-tetrazine-8-formic acid benzenesulfonyl furoxan esters compound, preparation method and use thereof |
| 06/04/2008 | CN101190916A Anticancer compound, preparation method and use thereof, and composition containing the compound |
| 06/04/2008 | CN101190329A Medicinal composition for regrouping human P43 protein and its application in medication |
| 06/04/2008 | CN101190259A Southern magnolia total lactone extract and preparation method and application thereof |
| 06/04/2008 | CN101190258A Total sesquiterpene lactone extract containing rich parthenolide and preparation method and application thereof |
| 06/04/2008 | CN101190214A Paclitaxel injection and preparation method thereof |
| 06/04/2008 | CN101190213A Docetaxel injection and preparation method thereof |
| 06/04/2008 | CN101190210A Application of triacontanol in preparing anti-cancer medicine |
| 06/04/2008 | CN101190188A Anthracene nucleus medicinal liposome injection and preparation method |
| 06/04/2008 | CN101189995A Acanthopanax giraldii harms tea |
| 06/04/2008 | CN100392087C Flavivirus vaccine delivery system |
| 06/04/2008 | CN100392084C Recombinant adenovirus containing codon optimized type IIPV16L1 gene |
| 06/04/2008 | CN100392080C Variable region of light chain and heavy chain genes of anti-KDR monoclonal antibody and its use |
| 06/04/2008 | CN100392074C Dendritic cell tumor vaccine and its preparation and use |
| 06/04/2008 | CN100391980C Antitumour multitarget composite antigen, its coding gene and application |
| 06/04/2008 | CN100391978C Recombinant anti-CD4 antibodies for human therapy |
| 06/04/2008 | CN100391976C High efficiency low poison immune toxin and its preparation method and application |
| 06/04/2008 | CN100391968C Goniothalamicim cyclopeptide B of anti-tumor compound and isomer and its preparing method |
| 06/04/2008 | CN100391958C Chemical compounds |
| 06/04/2008 | CN100391954C Enantiomers of thiophene hydroxamic acid derivatives and their use as hdac inhibitors |
| 06/04/2008 | CN100391543C Non-viral gene delivery system |
| 06/04/2008 | CN100391537C Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B |
| 06/04/2008 | CN100391525C Chinese medicine preparation for curing eophagus cancer |
| 06/04/2008 | CN100391515C Chinese patent medicine for treating primary lung cancer |
| 06/04/2008 | CN100391505C Medicine for treating esophagus cancer and cardia cancer and its preparation method |
| 06/04/2008 | CN100391471C Method for preparing platinum metal bunch with biological activity, and use thereof |
| 06/04/2008 | CN100391468C Protopanaxadiol lyophilized agent and its preparing method |
| 06/04/2008 | CN100391467C Nano emulsion of containing ginsenoside, preparation method and usage |
| 06/04/2008 | CN100391465C Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic |
| 06/04/2008 | CN100391464C Pharmaceutical compositions comprising active vitamin D compounds |
| 06/04/2008 | CN100391451C Application of cantharidin derivative in preparation of antitumour medicine |
| 06/04/2008 | CN100391446C Method of rearing and feeds |
| 06/04/2008 | CN100391440C Formulation based on heparin, glycosaminogl ycan or heparinoid, use of the formulation and the formulation base |
| 06/04/2008 | CN100391439C Immunopotentiators |
| 06/04/2008 | CN100391437C GM-CSF targeted medicine liposome for resisting acute myelogenous leukemia and preparation method thereof |
| 06/04/2008 | CN100391372C Acid diminating foxin eliminating anticancer traditional Chinese medicine tea and its preparation method |
| 06/03/2008 | US7381813 A modified estrogen receptor alpha ligand binding domain containing an amino acid modification in region 1, at region 2, or atleast one amino acid modifiation in both of regions, and these domain interacts with a nonendogenous ligand |
| 06/03/2008 | US7381808 Method and nucleic acids for the differentiation of prostate tumors |
| 06/03/2008 | US7381807 Of given nucleotide sequence; encapsulated in slow release delivery vehicle; includes viral or bacterial antigen; increases cell proliferation, differentiation, cytokine and antibody production for lymphocytes |
| 06/03/2008 | US7381710 Nucleic acid comprising a sequence encoding promyelocytic leukemia retinoic acid receptor alpha and a non-immunosuppressive inducer of tumor cell apoptosis which is arsenic; all-trans, 9-cis or 13-cis retinoic acid; or 4 allopurinol-l-ribonucleoside |
| 06/03/2008 | US7381704 Methods for use of short bioactive peptides |
| 06/03/2008 | US7381703 Aplidine for multiple myeloma treatment |
| 06/03/2008 | US7381699 Reagents and methods for smooth muscle therapies |
| 06/03/2008 | US7381560 Administering a chimeric anti-CD20 antibody; hybridomas; monoclonal antibodies |
| 06/03/2008 | US7381435 Composition for treating hepatitis C |
| 06/03/2008 | US7381429 Hormone replacemnent therapy; menopause, osteoporosis, cardiovascular disorders; stroke; sexual disorders |
| 06/03/2008 | US7381412 Monoclonal antibody for use in diagnosis, prevention and treatment of inflammatory disorders |
| 06/03/2008 | US7381411 Preventing influenza virus cell binding; schizophrenia; diagnosing chronic viral disease associated with cancer development |
| 06/03/2008 | CA2401711C Cyclic amide derivatives |
| 06/03/2008 | CA2382294C Use of docetaxel for treating hepatocellular carcinoma |
| 06/03/2008 | CA2313024C Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 06/03/2008 | CA2279846C Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 06/03/2008 | CA2261018C Treatment and diagnosis of cancer |
| 06/03/2008 | CA2243633C Isolated polypeptide for the skin and its use |
| 06/03/2008 | CA2160016C Method of forming oligonucleotides |
| 06/03/2008 | CA2106978C Compositions and methods for treating small cell and nonsmall cell lung cancers |
| 05/29/2008 | WO2008064093A2 Salts and crystal forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile |
| 05/29/2008 | WO2008064018A1 Thienopyrimidinones for treatment of inflammatory disorders and cancers |
| 05/29/2008 | WO2008064004A2 4-anilino-3-quinolinecarbonitriles for the treatment of acute myelogenous leukemia (aml) |
| 05/29/2008 | WO2008063912A1 Substituted pyrazole and triazole compounds as ksp inhibitors |
| 05/29/2008 | WO2008063671A2 Heterobicyclic metalloprotease inhibitors |
| 05/29/2008 | WO2008063670A1 Heterobicyclic matrix metalloprotease inhibitors |
| 05/29/2008 | WO2008063669A1 Heterobicyclic matrix metalloprotease inhibitors |
| 05/29/2008 | WO2008063644A1 Method of radio-sensitizing tumors using a radio-sensitizing agent |
| 05/29/2008 | WO2008063525A1 Compounds for inhibiting mitotic progression |
| 05/29/2008 | WO2008063229A2 Enzymatic debridement therapy for abnormal cell proliferation |
| 05/29/2008 | WO2008063129A1 Use of lipid containing particles comprising quillaja saponins for the treatment of cancer |
| 05/29/2008 | WO2008063116A1 Indozalyl sulphonamide derivatives useful as glucocorticoid modulators |
| 05/29/2008 | WO2008063045A1 Use of an anti-cancer compound |
| 05/29/2008 | WO2008062909A1 ENVIRONMENT-RESPONDING siRNA CARRIER USING DISULFIDE-BRIDGED POLYMERIC MICELLE |
| 05/29/2008 | WO2008062861A1 Extract powder of indigo-containing plant, method for production thereof, and use thereof |
| 05/29/2008 | WO2008062830A1 Spiroquinone compound and pharmaceutical composition |
| 05/29/2008 | WO2008062252A1 N-oxides of cytotoxic anthraquinones as hypoxia-targeting prodrugs in cancer treatment |
| 05/29/2008 | WO2008062235A1 Therapeutic g-quadruplex ligands |
| 05/29/2008 | WO2008062232A1 Depsipeptides and their therapeutic use |
| 05/29/2008 | WO2008062201A1 Depsipeptides and their therapeutic use |
| 05/29/2008 | WO2008062063A1 Novel antiproliferation antibodies |
| 05/29/2008 | WO2008061671A2 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels |
| 05/29/2008 | WO2008061647A1 Use of a compound as vegf inhibitor |
| 05/29/2008 | WO2008061429A1 Use of triacontanol in preparation of medicaments for treatment of cancers |
| 05/29/2008 | WO2008061392A1 Method for preparing cell populations with anti-tumor immune response activity |